The nitric oxide donor sodium nitroprusside inhibits mineralization in ATDC5 cells

Calcified Tissue International

Volumn 78, Issue 3, 2006, Pages 171-177

  Huitema, L F A ^a,b   Vaandrager, A B ^a   Van Weeren, P R ^b   Barneveld, A ^b   Helms, J B ^a   Van De Lest, C H A ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Chondrocyte; Inorganic phosphate; Mineralization; Sodium nitroprusside

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMINE CYCLIC GUANOSINE 3',5' MONOPHOSPHATE; ALIZARIN RED S; CALCIUM; CYCLIC GMP; CYCLIC GMP DERIVATIVE; GLYCEROL 2 PHOSPHATE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BONE MINERALIZATION; CARTILAGE CELL; CELL CULTURE; DONOR; DRUG EFFECT; EMBRYO; INHIBITION KINETICS; MOUSE; NONHUMAN; PATHOGENESIS; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; STEM CELL;

ANIMALS; ANTHRAQUINONES; APOPTOSIS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL CULTURE TECHNIQUES; CELL LINE; CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTOCYTOCHEMISTRY; MICE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHATES; SPECTROPHOTOMETRY, ATOMIC;

EID: 33645289143     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-005-1233-y     Document Type: Article

References (52)

1. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332-336
2. Cancedda R, Castagnola P, Cancedda FD, Dozin B, Quarto (2000) Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol 44:707-714
3. Shum L, Coleman CM, Hatakeyama Y, Tuan RS (2003) Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today 69:102-122
4. Giachelli CM (1999) Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol 154:671-675
5. Magne D, Julien M, Vinatier C, Merhi-Soussi F, Weiss P, Guicheux J (2005) Cartilage formation in growth plate and arteries: from physiology to pathology. Bioessays 27:708-716
6. Kalya S, Rosenthal AK (2005) Extracellular matrix changes regulate calcium crystal formation in articular cartilage. Curr Opin Rheumatol 17:325-329
7. Demer LL, Tintut Y (2003) Mineral exploration: search for the mechanism of vascular calcification and beyond. The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 23:1739-1743
8. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168-2176
9. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809
10. Bobryshev YV (2005) Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol 205:641-650
11. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM (2003) Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23:489-494
12. Hsu HH, Camacho NP (1999) Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 143:353-362
13. Hsu HH, Camacho NP, Sun F, Tawfik O, Aono H (2000) Isolation of calcifiable vesicles from aortas of rabbits fed with high cholesterol diets. Atherosclerosis 153:337-348
14. Hsu HH, Camacho NC, Tawfik O, Sun F (2002) Induction of calcification in rabbit aortas by high cholesterol diets: roles of calcifiable vesicles in dystrophic calcification. Atherosclerosis 161:85-94
15. Kirsch T, Nah HD, Shapiro IM, Pacifici M (1997) Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 137:1149-1160
16. Anderson HC (1995) Molecular biology of matrix vesicles. Clin Orthop 314:266-280
17. Li H, Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254
18. Alexander RW, Dzau VJ (2000) Vascular biology: the past 50 years. Circulation 102:IV112-IV116
19. Jang D, Murrell GA (1998) Nitric oxide in arthritis. Free Radic Biol Med 24:1511-1519
20. van't Hof RJ, Ralston SH (2001) Nitric oxide and bone. Immunology 103:255-261
21. Fujishige K, Kotera J, Yanaka N, Akatsuka H, Omori K (1999) Alteration of cGMP metabolism during chondrogenic differentiation of chondroprogenitor-like EC cells, ATDC5. Biochim Biophys Acta 1452:219-227
22. Krumenacker JS, Hanafy KA, Murad F (2004) Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res Bull 62:505-515
23. Ozasa A, Komatsu Y, Yasoda A, Miura M, Sakuma Y, Nakatsuru Y, Arai H, Itoh N, Nakao K (2005) Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36:1056-1064
24. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fassler R (1996) Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274:2082-2086
25. Shukunami C, Shigeno C, Atsumi T, Ishizeki K, Suzuki F, Hiraki Y (1996) Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/ PTH-related peptide receptor. J Cell Biol 133:457-468
26. Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y (1997) Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res 12:1174-1188
27. Magne D, Bluteau G, Faucheux C, Palmer G, Vignes-Colombeix C, Pilet P, Rouillon T, Caverzasio J, Weiss P, Daculsi G, Guicheux J (2003) Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 18:1430-1442
28. Bellows CG, Aubin JE, Heersche JN (1991) Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner 14:27-40
29. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279:R1365-R1377
30. Kergosien N, Sautier J, Forest N (1998) Gene and protein expression during differentiation and matrix mineralization in a chondrocyte cell culture system. Calcif Tissue Int 62:114-121
31. Loty S, Sautier JM, Loty C, Boulekbache H, Kokubo T, Forest N (1998) Cartilage formation by fetal rat chondrocytes cultured in alginate beads: a proposed model for investigating tissue-biomaterial interactions. J Biomed Mater Res 42:213-222
32. Lunstrum GP, Keene DR, Weksler NB, Cho YJ, Cornwall M, Horton WA (1999) Chondrocyte differentiation in a rat mesenchymal cell line. J Histochem Cytochem 47:1-6
33. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270:9420-9428
34. Mansfield K, Rajpurohit R, Shapiro IM (1999) Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol 179:276-286
35. Mansfield K, Teixeira CC, Adams CS, Shapiro IM (2001) Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 28:1-8
36. Palmer G, Zhao J, Bonjour J, Hofstetter W, Caverzasio J (1999) In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 24:1-7
37. Mansfield K, Pucci B, Adams CS, Shapiro IM (2003) Induction of apoptosis in skeletal tissues: phosphate-mediated chick chondrocyte apoptosis is calcium dependent. Calcif Tissue Int 73:161-172
38. Fiscus RR (2002) Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 11:175-190
39. Zech B, Kohl R, von Knethen A, Brune B (2003) Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem J 371:1055-1064
40. Chan SL, Fiscus RR (2003) Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG. Mol Hum Reprod 9:775-783
41. Yoshioka Y, Yamamuro A, Maeda S (2003) Nitric oxide at a low concentration protects murine macrophage RAW264 cells against nitric oxide-induced death via cGMP signaling pathway. Br J Pharmacol 139:28-34
42. Kirsch T, Wang W, Pfander D (2003) Functional differences between growth plate apoptotic bodies and matrix vesicles. J Bone Miner Res 18:1872-1881
43. Matsumoto A, Comatas KE, Liu L, Stamler JS (2003) Screening for nitric oxide-dependent protein-protein interactions. Science 301:657-661
44. Mahidhara RS, Hoffman RA, Huang S, Wolf-Johnston A, Vodovotz Y, Simmons RL, Billiar TR (2003) Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74:403-411
45. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, Seegmiller JE, Terkeltaub R, Lotz M (1998) Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 95:3094-3099
46. Cheung HS, Ryan LM (1999) Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies. Osteoarthritis Cartilage 7:409-412
47. Kirsch T, Harrison G, Golub EE, Nah HD (2000) The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem 275:35577-35583
48. 2+ influx regulates growth plate chondrocyte maturation and apoptosis. J Biol Chem 278:3762-3769
49. Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH (1998) Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J Immunol 160:1444-1448
50. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE (1997) Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 40:261-269
51. Scheller M, Zimmermann B, Bernimoulin JP, Scholz P (1995) Induction of metalloproteinase activity, cartilage matrix degradation and inhibition of endochondral mineralization in vitro by E. coli lipopolysaccharide is mediated by interleukin 1 alpha. Cytokine 7:331-337
52. Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686-E696